1-20 of 77
Douglas A. Stewart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improving the Utilization and Tolerability of Thiotepa-Based Autologous Stem Cell Transplantation in Primary CNS Lymphoma

Robert Puckrin, Colin Stewart, Carolyn Owen, Lesley E. Street, Sarah Perry, Peter Duggan, Mona Shafey, Neil Chua, Douglas A. Stewart
Journal: Blood
Blood (2023) 142 (Supplement 1): 3595.
https://doi.org/10.1182/blood-2023-178085
Published: 2023
Journal Articles

Long-Term Remissions after First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma

Colin Stewart, Carolyn Owen, Neil Chua, Anthea Peters, Mona Shafey, Douglas A. Stewart, Robert Puckrin
Journal: Blood
Blood (2023) 142 (Supplement 1): 3599.
https://doi.org/10.1182/blood-2023-178097
Published: 2023
Journal Articles

Intensity of Survivin Expression Correlates with Clinical and Biological Markers of Aggressive R/R DLBCL

Sila Usta, Alexandra Misura, Kim Roos, Iran Rashedi, Irina Amitai, Yidi Jiang, Kathryn Mangoff, Gail Klein, Nicholas Allen Forward, Douglas A. Stewart, Joy Mangel, George A. Tomlinson, Hubert Tsui, Neil Berinstein
Journal: Blood
Blood (2023) 142 (Supplement 1): 6124.
https://doi.org/10.1182/blood-2023-189200
Published: 2023
Journal Articles

Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) - Outcome of Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (R-DICEP) Versus R-GDP

Douglas A. Stewart, Lois E. Shepherd, Jill J. Dudebout, Jean-François Larouche, Neil Chua, Tara Baetz, Michael Crump, Mona Shafey, Nizar Abdel-Samad, Sue Robinson, Isabelle Fleury, Deborah Marcellus, Pamela Skrabek, Jesse Kelly, Annette E. Hay, Bingshu Chen, John Kuruvilla
Journal: Blood
Blood (2022) 140 (Supplement 1): 3734–3736.
https://doi.org/10.1182/blood-2022-163706
Published: 2022
Journal Articles

Real-World Outcomes of Consolidative Autotransplant for High-Risk Large B-Cell Lymphoma

Robert Puckrin, Russell Sterrett, Neil Chua, Carolyn Owen, Peter Duggan, Mona Shafey, Douglas A. Stewart
Journal: Blood
Blood (2022) 140 (Supplement 1): 10581–10582.
https://doi.org/10.1182/blood-2022-162850
Published: 2022
Journal Articles

Outcomes in Relapsed/Refractory Burkitt Lymphoma: A Multi-Centre Canadian Experience

Farheen Manji, Eric Chow, Alina S. Gerrie, Neil Chua, Robert Puckrin, Douglas A. Stewart, Pamela Skrabek, Isabelle Bence-Bruckler, Mary-Margaret Keating, Joanne Britto, Gwynivere A Davies, Vishal Kukreti, John Kuruvilla, Michael Crump
Journal: Blood
Blood (2021) 138 (Supplement 1): 2525.
https://doi.org/10.1182/blood-2021-146036
Published: 2021
Journal Articles

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Katharine Louise Lewis, Lasse H. Jakobsen, Diego Villa, Sabela Bobillo, Karin Ekstroem Smedby, Kerry J. Savage, Toby A. Eyre, Kate Cwynarski, Paris L Caporn, Joan Van Zyl, Magdalena Klanova, Marek Trněný, Robert Puckrin, Douglas A. Stewart, Mark J Bishton, Christopher P. Fox, Aung M Tun, Gita Thanarajasingam, Faouzi Djebbari, Erel Joffe, Sandra Eloranta, Sara Harrysson, Laurie H. Sehn, Seth M Maliske, Kittika Poonsombudlert, Xiao Guo, Greg Hapgood, Kate Manos, Eliza Hawkes, Jahanzaib Khwaja, Adrian Minson, Michael Dickinson, Andreas Kiesbye Øvlisen, Gareth P Gregory, Michael Gilbertson, Isaac T Streit, Hamish W Scott, Matthew Ku, Sanjay de Mel, Kar Ying Yong, Liu Xin, Mridula Mokoonlall, Dipti Talaulikar, Nicholas L McVilly, Anna Johnston, Matthew J Brunner, Priyanka A Pophali, Matthew J. Maurer, Tarec Christoffer El-Galaly, Chan Yoon Cheah
Journal: Blood
Blood (2021) 138 (Supplement 1): 181.
https://doi.org/10.1182/blood-2021-146737
Published: 2021
Journal Articles

Favorable Outcomes with Thiotepa/Busulfan-Based Conditioning and Autotransplant for Patients with Aggressive B-Cell Lymphoma and Secondary CNS Involvement

Robert Puckrin, Neil Chua, Mona Shafey, Douglas A. Stewart
Journal: Blood
Blood (2021) 138 (Supplement 1): 2912.
https://doi.org/10.1182/blood-2021-146103
Published: 2021
Journal Articles

Real World Characteristics and Outcomes of Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma; A Provincial Experience

Farheen Manji, MD, Douglas A. Stewart, MD FRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-139850
Published: 2020
Journal Articles

Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Nicholas Allen Forward, MDMSc,FRCPC, Pierre Laneuville, MD FRCPC, Joy Mangel, MD FRCPC, Douglas A. Stewart, MD FRCPC, Irina Amitai, MD, Gail Klein, MSc, Nancy Pennell, BSc, Iran Rashedi, MD MSc, Kim Roos, BA, BSc, Yogesh Bramhecha, Rebekah Conlon, RN
Journal: Blood
Blood (2020) 136 (Supplement 1): 16.
https://doi.org/10.1182/blood-2020-136751
Published: 2020
Journal Articles

Generalizability of Landmark Clinical Trials in Diffuse Large B Cell Lymphoma to Real-World Patients: A Single-Centre Retrospective Cohort Study

Marta Davidson, MDPhDFRCPC, Alexandra Rice, MD, Douglas A. Stewart, MD FRCPC, Carolyn Owen, MDFRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-137541
Published: 2020
Journal Articles

Plasmablastic Lymphoma: Synergism between Wnt/B-Catenin and the RAS S ignalling Molecules May Identify Potential Targets for Therapy

Hamza Kamran, BSc, Ariz Akhter, PhD, Hassan Rizwan, B.Sc, Meer-Taher Shahbani-Rad, MDFRCPC, Ghaleb Elyamany, MDPhD FRCPC, Douglas A. Stewart, MD FRCPC, Adnan Mansoor, MDFRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 36.
https://doi.org/10.1182/blood-2020-140651
Published: 2020
Journal Articles

Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada

Robert Puckrin, MD, Haidar El Darsa, MD, Sunita Ghosh, PhD P Stat, Anthea Peters, MSc, MD FRCPC, Douglas A. Stewart, MD FRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-139025
Published: 2020
Journal Articles

Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Pierre Laneuville, MD FRCPC, Douglas A. Stewart, MD, Nicholas Allen Forward, MDMSc,FRCPC, Liam Smyth, MDFRCPath, Gail Klein, MSc, Nancy Pennell, BSc, Kim Roos, BA, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3236.
https://doi.org/10.1182/blood-2019-125963
Published: 2019
Journal Articles

Autologous Transplantation Improves Survival Rates for Follicular Lymphoma Patients Who Relapse within 2-Years of Chemoimmunotherapy: A Multi-Centre Retrospective Analysis of Consecutively Treated Patients in the Real World

Mita Manna, MD FRCPC, Richard Lee-Ying, MD FRCPC, Gwynivere Davies, MDFRCPC, Anthea Peters, MSc, MD FRCPC, Danielle Oh, MD, Colin Stewart, Douglas A. Stewart
Journal: Blood
Blood (2017) 130 (Supplement 1): 3298.
https://doi.org/10.1182/blood.V130.Suppl_1.3298.3298
Published: 2017
Journal Articles

Phase I/II Study of Infusional Gemcitabine and High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation for Patients with Relapsed/Refractory Lymphoma: Interim Safety Analysis

Marta Davidson, MDPhD, Douglas A. Stewart, Peter Duggan, MD FRCPC, Andrew Daly, MD, Mona Shafey, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4534.
https://doi.org/10.1182/blood.V130.Suppl_1.4534.4534
Published: 2017
Journal Articles

Significant Adverse Consequences of Initial Watchful Waiting for Follicular Lymphoma Patients: A Retrospective Analysis of Patients Diagnosed in Alberta from 1994-2011

Gwynivere Davies, MDFRCPC, Sunita Ghosh, PhD P Stat, Danielle Oh, MD, Mita Manna, MD FRCPC, Anthea Peters, MSc, MD FRCPC, Colin Stewart, Douglas A. Stewart
Journal: Blood
Blood (2017) 130 (Supplement 1): 4041.
https://doi.org/10.1182/blood.V130.Suppl_1.4041.4041
Published: 2017
Journal Articles

Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis

Patrick J. Stiff, MD, Hongli Li, PhD, James R. Cook, MD PhD, Louis S. Constine, MD, Stephen Couban, MD, Douglas A. Stewart, MD FRCPC, Thomas C. Shea, MD, Pierluigi Porcu, MD, Jane N. Winter, MD, Brad S Kahl, Sonali M. Smith, MD, Deborah Marcellus, MD, Kevin Barton, MD, Glenn M. Mills, MD, Michael LeBlanc, PhD, Lisa Rimsza, MD, Stephen J. Forman, MD, John P. Leonard, MD, Richard I. Fisher, MD, Jonathan Friedberg, MD
Journal: Blood
Blood (2016) 128 (22): 4651.
https://doi.org/10.1182/blood.V128.22.4651.4651
Published: 2016
Journal Articles

Gene-Expression for Prediction of Disease Progression Following Initial Management of Follicular Lymphoma

Etienne Mahe, BSc, MD FRCPC, Ariz Akhter, PhD, Danielle H. Oh, MB ChB, Fahad Farooq, BSc, Meer-Taher Shabani-Rad, MD FRCPC, Adnan Mansoor, MD FRCPC, Douglas A. Stewart, MD FRCPC
Journal: Blood
Blood (2015) 126 (23): 4804.
https://doi.org/10.1182/blood.V126.23.4804.4804
Published: 2015
Journal Articles

Myeloablative Allogeneic Stem Cell Transplantation in CLL: A Single Centre Retrospective Study

Sonia Cerquozzi, MD FRCPC, Sunita Ghosh, PhD, P.Stat., Diana Quinlan, Amy Trottier, MD, Mary Lynn Savoie, MD FRCPC, Douglas A. Stewart, MD FRCPC, James A. Russell, MD FRCPC, Carolyn Owen, MD MDes (UK), FRCPC
Journal: Blood
Blood (2015) 126 (23): 5530.
https://doi.org/10.1182/blood.V126.23.5530.5530
Published: 2015